Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Zang YS"'
Publikováno v:
Cancer Management and Research, Vol Volume 10, Pp 439-446 (2018)
Bao-Dong Qin,* Xiao-Dong Jiao,* Ling-Yan Yuan, Ke Liu, Yuan-Sheng Zang Department of Medical Oncology, Changzheng Hospital, Second Military Medical University, Shanghai, China *These authors contributed equally to this work Introduction: Adenosquamou
Externí odkaz:
https://doaj.org/article/c7fcf5bebe0a46d189c46f919fb248e3
Publikováno v:
OncoTargets and Therapy, Vol Volume 13, Pp 11849-11853 (2020)
Zhan Wang,1,* Chen-Yang Ye,1,* Wen-Li Zhou,1 Miao-Miao Wang,1 Wei-Ping Dai,1 Jingjing Zheng,2 Yuan-Sheng Zang1 1Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200003, People’s Republic of China; 2Burning Roc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::58ff4fd5496d383bf1f7d1644d74574c
https://www.dovepress.com/the-role-of-dynamic-ctdna-monitoring-during-combination-therapies-of-b-peer-reviewed-article-OTT
https://www.dovepress.com/the-role-of-dynamic-ctdna-monitoring-during-combination-therapies-of-b-peer-reviewed-article-OTT
Publikováno v:
OncoTargets and Therapy, Vol Volume 13, Pp 6289-6293 (2020)
Jin-Ju Guo,1,2,* Xiao-Dong Jiao,1,* Ying Wu,1,* Bao-Dong Qin,1 Ke Liu,1 Yuan-Sheng Zang1 1Department of Medical Oncology, Changzheng Hospital, Second Military Medical University, Shanghai 200072, People’s Republic of China; 2Department of Medical O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::8d81fe2e4e39928e1a77d0e07b99e84b
https://www.dovepress.com/response-to-pyrotinib-in-a-chinese-patient-with-bone-metastatic-scrota-peer-reviewed-article-OTT
https://www.dovepress.com/response-to-pyrotinib-in-a-chinese-patient-with-bone-metastatic-scrota-peer-reviewed-article-OTT
Publikováno v:
OncoTargets and Therapy, Vol Volume 12, Pp 443-447 (2019)
Zhan Wang*, Wei-Ping Dai*, Yuan-Sheng Zang Department of Medical Oncology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China *These authors contributed equally to this work Background: Patients with BRAF (v-Raf murine sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::2b911d95b712af2b0d1af410793563ae
https://www.dovepress.com/complete-response-with-fluorouracil-and-irinotecan-with-a-brafv600e-an-peer-reviewed-article-OTT
https://www.dovepress.com/complete-response-with-fluorouracil-and-irinotecan-with-a-brafv600e-an-peer-reviewed-article-OTT
Publikováno v:
OncoTargets and Therapy, Vol Volume 11, Pp 4739-4745 (2018)
Bao-Dong Qin,* Xiao-Dong Jiao,* Ling-Yan Yuan,* Ke Liu, Zhan Wang, Wen-Xing Qin, Yuan-Sheng Zang Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200072, China *These authors contributed equally to this work Abs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::74fa8d98969fdc64f7c8089ac9e99c6b
https://www.dovepress.com/the-effectiveness-of-afatinib-and-osimertinib-in-a-chinese-patient-wit-peer-reviewed-article-OTT
https://www.dovepress.com/the-effectiveness-of-afatinib-and-osimertinib-in-a-chinese-patient-wit-peer-reviewed-article-OTT
Publikováno v:
Oncologist; Jan2008, Vol. 13 Issue 1, p79-81, 3p
Autor:
Sun X; Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China., Zang YS; Department of Rheumatology and Immunology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China., Xu Y; Department of Rheumatology and Immunology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China., Wang W; Department of Rheumatology and Immunology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2024 Sep 05; Vol. 11, pp. 1470068. Date of Electronic Publication: 2024 Sep 05 (Print Publication: 2024).
Autor:
Qin BD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China., Jiao XD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China., Yuan LY; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China., Wu Y; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China., Ling Y; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China., Zang YS; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China doctorzangys@163.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Apr 16; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 16.
Autor:
Duan XP; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China., Qin BD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China., Jiao XD; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China., Liu K; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China., Wang Z; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China., Zang YS; Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China. doctorzangys@163.com.
Publikováno v:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Mar 04; Vol. 9 (1), pp. 57. Date of Electronic Publication: 2024 Mar 04.
Autor:
Wang LS; Department of Medical Oncology, Huainan Yangguangxinkang Hospital, Huainan., Chen SQ; Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University, Shanghai, China., Zhong X; Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University, Shanghai, China., Jiao XD; Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University, Shanghai, China., Liu K; Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University, Shanghai, China., Qin BD; Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University, Shanghai, China., Wu Y; Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University, Shanghai, China., Ling Y; Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University, Shanghai, China., Duan XP; Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University, Shanghai, China., Zang YS; Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Publikováno v:
Anti-cancer drugs [Anticancer Drugs] 2023 Nov 01; Vol. 34 (10), pp. 1146-1150. Date of Electronic Publication: 2022 Dec 23.